Wayne Danson

Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY.

Re-Act Enterprises, Inc. currently has no operations. It was previously engaged in the supply chain and consumer electronic after market services business. The company was founded on April 30, 1998 and is headquartered in Lawrenceville, GA.

Part of Re-Act Enterprises, Inc., Encompass Parts Distribution is a leading supplier of original replacement parts and accessories for almost 200 brands of consumer electronics, appliances, computers, tablets, personal care items, service aids, health and wellness items, mobile phones, HVACs, and TV & audio equipment. The company is based in Lawrenceville, GA and provides parts from over 200 manufacturers, with millions of parts available for same-day shipping from all trusted brands. With over 60 years of experience, Encompass is committed to providing superior service every step of the way, and is a trusted source of genuine parts. The company offers special payment options and a helpful parts knowledge repository for dealers and servicers.

The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY.

New York State Society of Certified Public Accountants is a non-profit organization. It provides a membership program for certified public accountants that offers in-person and online networking opportunities, Continuing Professional Education courses and conferences, the CPA Journal, and other publications. The company was foudned in 1897 and is headquartered in New York, NY.

ImmunoCellular Therapeutics, Ltd. is a clinical-stage pharmaceutical company, focused on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ.